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Summary 
Regulation of androgen receptor (AR) mRNA expression was studied in Sertoli cells and peritubular 
myoid cells isolated from immature rat testis, and in the lymph node carcinoma cell line derived from a 
human prostate (LNCaP). Addition of dibutyryl-cyclic AMP (dbcAMP) to Sertoli cell cultures resulted in 
a rapid transient decrease in AR mRNA expression (5 h), which was followed by a gradual increase in 
AR mRNA expression (24-72 h). This effect of dbcAMP mimicked follicle-stimulating hormone (FSH) 
action. In peritubular myoid cells, there was only a moderate but prolonged decrease during incubation 
in the presence of dbcAMP, and in LNCaP cells no effect of dbcAMP on AR mRNA expression was 
observed. 
When Sertoli cells or peritubular myoid cells were cultured in the presence of androgens, AR mRNA 
expression in these cell types did not change. This is in contrast to LNCaP cells, that showed a marked 
reduction of AR mRNA expression during androgen treatment. 
In the present experiments, transcriptional regulation of AR gene expression in Sertoli cells and 
LNCaP cells was also examined. Freshly isolated Sertoli cell clusters were transfected with a series of 
luciferase reporter gene constructs, driven by the AR promoter. It was found that addition of dbcAMP to 
the transfected Sertoli cells resulted in a small but consistent increase in reporter gene expression (which 
was interpreted as resulting from AR promoter activity); a construct that only contained the AR 5’ 
untranslated region of the cDNA sequence did not show such a regulation. The same constructs, 
transfected into LNCaP cells, did not show any transcriptional down-regulation when the synthetic 
androgen R1881 was added to the cell cultures. A nuclear transcription elongation experiment (run-on), 
however, demonstrated that androgen-induced AR mRNA down-regulation in LNCaP cells resulted 
from an inhibition of AR gene transcription. 
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The present results indicate that in Sertoli cells and LNCaP cells, hormonal effects on AR gene 
transcription play a role in regulation of AR expression. However, AR gene transcription in these cells is 
differentially regulated. 
Introduction 
In the mammalian testis, follicle-stimulating 
hormone (FSH) and testosterone exert co-oper- 
ative actions in the initiation and maintenance of 
spermatogenesis (Clermont and Harvey, 1967; 
Steinberger, 1971; Hansson et al., 1975; Fritz, 
1978; Marshall and Nieschlag, 1987; Russell et 
al., 1987; Bartlett et al., 1989; Matsumoto and 
Bremner, 1989). In general, the quality and quan- 
tity of spermatogenesis are used as a parameter 
to evaluate the relative importance of FSH and 
testosterone. Using cultured Sertoli cells, several 
specific or common actions of FSH and testos- 
terone, in particular on protein synthesis, have 
been observed (Cheng et al., 1986). Recently, 
co-operation between FSH and testosterone has 
been observed on the level of androgen receptor 
(AR) regulation. In cultured immature rat Sertoli 
cells, long-term (72 h) addition of FSH to the 
culture medium resulted in an increased expres- 
sion of both AR mRNA and protein (Verhoeven 
and Cailleau, 1988; Blok et al., 1989, 1992b; San- 
born et al., 1991). Testosterone addition to the 
cultured cells did not markedly affect AR mRNA 
expression, but resulted in increased stability of 
AR protein (Blok et al., 1989, 1992b). The effects 
of FSH and testosterone on the expression of AR 
protein appeared to be additive (Blok et al., 1989, 
1992b). 
Sertoli cells and peritubular myoid cells are an 
important source of AR protein in the rat testis 
(Takeda et al., 1989; Sar et al., 1990). To obtain 
more information on regulation of AR mRNA 
expression in these testicular cell types, Sertoli 
cells and peritubular myoid cells were isolated 
from immature rats and cultured in the presence 
or absence of FSH, dbcAMP or testosterone. 
LNCaP cells (cell line derived from a lymph node 
metastasis from a human prostate carcinoma, 
Horoszewicz et al., 1983) were included in this 
analysis, because androgen-induced down-regu- 
lation of AR mRNA expression is a more general 
phenomenon which also occurs in these cells 
(Quarmby et al., 1990; Tilley et al., 1990; Trap- 
man et al., 1990; Krongrad et al., 1991). Northern 
blotting was performed to analyze the regulation 
of AR mRNA expression in the different cell 
types. 
Structural analysis of the rat and human AR 
promoter region (Baarends et al., 1990; Faber et 
al., 1991) did not reveal the presence of consen- 
sus sequences that could act as cyclic AMP re- 
sponse elements (CRE) through which FSH could 
regulate AR gene transcription. Several glucocor- 
ticoid response element (GRE) half-sites were 
found in the AR promoter, but it remains to be 
established whether these GRE half-sites are 
functional in the regulation of AR gene transcrip- 
tion. To study whether or not regulation of AR 
mRNA expression by FSH (Sertoli cells) and 
testosterone (LNCaP cells) is caused by changes 
in AR gene transcription, rather than through an 
effect on mRNA stability, reporter constructs 
were made that contained up to 7 kb 5’ upstream 
sequences of the AR gene start site. These con- 
structs were transfected into cultured immature 
Sertoli cells and LNCaP cells, to test regulation 
of their transcription. Regulation of AR gene 
transcription by FSH or testosterone was also 
studied using a nuclear transcription elongation 
(nuclear run-on> assay. 
Materials and methods 
Cell culture for RNA isolation and nuclear run-on 
Sertoli cells were isolated from 15day-old rats, 
and cultured as described by Themmen et al. 
(1991). Peritubular myoid cells were obtained 
from the same testes as the Sertoli cells, as fol- 
lows. The testes were decapsulated and incubated 
in 20 ml phosphate-buffered saline (PBS) con- 
taining 5 pg/ml DNase (DN-25; Sigma, St. Louis, 
MO, USA), 1 mg/ml collagenase A (Boehringer 
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Mannheim, Mannheim, Germany), 1 mg/ml 
hyaluronidase (I-S; Sigma), and 1 mg/ml trypsin 
(TRL, Cooper Biomedical, Freehold, NJ, USA), 
for 25 min at 37°C in a 100 ml Erlenmeyer flask, 
in a shaking waterbath (120 cycles/min). During 
this treatment, interstitial and peritubular myoid 
cells became dissociated from the seminiferous 
tubule fragments; these fragments were removed 
by sedimentation at unit gravity for 2 min in 50 
ml PBS containing 5 pg/ml DNase. The super- 
natant was filtered through a 60 pm nylon filter, 
and centrifuged for 2 min at 7 X g. The cells in 
the supernatant were precipitated by centrifuga- 
tion at 30 x g for 2 min. The interstitial and 
peritubular myoid cells were seeded at a density 
of approximately 3 x lo4 cells per cm*, in Eagle’s 
minimum essential medium (Gibco BRL, Middle- 
sex, UK), supplemented with antibiotics and 
non-essential amino acids (MEM; Oonk et al., 
1985) and containing 10% foetal calf serum (FCS). 
At the beginning of the culture period, the cell 
preparation contained approximately 50% peri- 
tubular myoid cells, as determined by alkaline 
phosphatase staining (Palombi et al., 1989). The 
cultures were grown to near confluency in 3 days. 
The purity at that time was higher than 95%. All 
experiments with peritubular myoid cells were 
performed in MEM containing 0.1% bovine serum 
albumin (BSA, fraction V, Sigma). The cells were 
cultured in the presence or absence of hormones 
as indicated in the Results section. 
LNCaP cells (passages 45-50) were cultured in 
RPMI, containing antibiotics (see above) and 
7.5% FCS, to 50% confluency. To study regula- 
tion of AR mRNA expression (Northern blotting 
and nuclear run-on analyses), the cells were cul- 
tured in RPM1 containing 7.5% Dextran-coated 
charcoal-treated FCS (DCC-FCS), supplemented 
with hormones as indicated in the Results sec- 
tion. 
Total RNA was isolated from Sertoli, peri- 
tubular myoid and LNCaP cells as described by 
Blok et al. (1992a). The nuclear run-on assays 
were carried out in duplicate as described by 
Blok et al. (1992b). In this assay, the transcription 
elongation was allowed to continue for 30 min in 
the isolated nuclei, in the presence of labelled 
mRNA precursors. The mRNAs were hybridized 
to the complete human AR cDNA (Trapman et 
al., 1988; Faber et al., 1991; Jenster et al., 1991), 
and autoradiographed. The films were scanned 
using a video densitometer (Bio-Rad, model 620). 
Isolation and transfection of Sertoli cell clusters 
Tubule fragments obtained from testes from 
15day-old rats in the procedure for isolation of 
peritubular myoid cells (see above), were the 
source of Sertoli cell clusters that were used for 
transfection. The tubule fragments, cell clusters 
consisting of Sertoli cells with a few adherent 
germ cells (mainly spermatocytes), were allowed 
to attach in plastic Petri dishes (60 X 15 mm, 
Nunclon, Roskilde, Denmark), at a density of 
approximately 3 X lo5 cells/cm2, for 4 h before 
transfection. The Sertoli cell clusters were cul- 
tured in MEM, at 37°C under an atmosphere of 
5% CO, in air, in the presence of 5% DCC-FCS. 
DNA precipitate was produced using the cal- 
cium phosphate method (Chen and Okayama, 
1987). Per culture dish with 4 ml medium, 250 ~1 
precipitate containing 5 pg plasmid DNA con- 
struct was added, and kept on the cells for 15 h. 
Subsequently, the cells were washed with PBS 
(without Ca2+ and Mg’+) before being subjected 
to a 1.5 min shock treatment with 15% (v/v) 
glycerol in PBS (without Ca2+ and Mg2+). This 
was followed by ‘two wash steps and addition of 
fresh medium (MEM supplemented with 5% 
DCC-FCS). After a 6 h incubation period, the 
medium was again replaced by fresh medium 
supplemented with or without hormones. The 
incubations of the Sertoli cells with of without 
hormones were continued for 24 h because Blok 
et al. (1992b) have reported a significant increase 
in AR mRNA and protein expression after 24 h 
of culture in the presence of FSH. In a number of 
experiments, the pCHll0 P-galactosidase xpres- 
sion plasmid (Pharmacia LKB Biotechnology, 
Uppsala, Sweden) was co-transfected as an inter- 
nal control. Within one experiment, all incuba- 
tions were terminated at the same time point 
(control and hormone-treated). The hormone 
treatment protocols are described in the Results 
section. 
The cells were harvested in 0.5 ml extraction 
buffer (100 mM Tris pH 7.8, 8 mM MgCl,, 1 mM 
dithiothreitol, 15% glycerol, 0.2% Triton X-100). 
For estimation of luciferase activity, a small test 
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tube containing 40 ~1 of this reaction mixture was were repeated 4-5 times, using different cell iso- 
placed in a luminometer (Pica-lite 6100; Packard, lates and plasmid preparations. The presented 
Downers Grove, IL, USA), and the reaction was luciferase activities are from four different trans- 
initiated by injection of 10 ~1 of 0.5 mM luciferin fections in one representative xperiment. 
(Sigma), 50 mM ATP, pH 7. Light emission was Alkaline phosphatase staining was used to 
measured during the first 1.5 s of the reaction evaluate contamination with peritubular myoid 
(integral mode). The transfection experiments cells in the Sertoli cell clusters (Palombi et al., 
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Fig. 1. AR gene promoter/reporter constructs. Constructs l-4 contain regions of the AR gene promoter (Baarends et al., 1990). 
Construct 5 contains the 5’ untranslated region of the cDNA sequence from the AR gene, cloned in front of a minimal promoter 
(Ott-6 promoter). Constructs 6 and 7 are controls for the basal rate of luciferase gene transcription. Construct 7 is a positive 
control for AR-stimulated transcription, and construct 8 is a positive control for dbcAMP-stimulated transcription. 
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1989). This contamination was below 3%, and the 
contamination with spermatocytes was approxi- 
mately IO% (at the end of the incubations)_ 
LNCaP cell transfection 
LNCaP cells were cultured in MEM contain- 
ing 7.5% DCC-FCS, and transfected as described 
for Sertoli cells. The transfected cells were stimu- 
lated for 24 h with hormones, as described in the 
Results section, and harvested to measure the 
luciferase activity. The transfection experiments 
were repeated 4-5 times. The presented lu- 
ciferase activities are frome four different trans- 
fections in one representative xperiment. 
Plasmids 
For construction of most plasmids, the pSLA3 
vector was used (van Dijk et al., 1991) that is a 
derivative of pSuperCAT. Several restriction 
fragments derived from GrAR2 (Baarends et al., 
1990) were subcloned into pSLA3, using standard 
methods (Sambrook et al., 1989). In a number of 
constructs, an octamer binding protein promoter 
(mouse Ott-6; kindly provided by Dr. D. Meijer, 
Rotterdam, Netherlands) was used as a minimal 
promoter. 
The pSLA3-E3K promoter/reporter construct 
was generated as follows. A 1.5 kb KpnI/EcoRI 
fragment derived from GrAR2, containing the 
AR promoter and 5’ untranslated region of the 
cDNA (- 435 to + 966) (Fig. 11, was inserted in 
the KpnI and EcoRI sites of pGEM (pGEM- 
E3K). From this vector, a ClaI/EcoRI fragment 
was isolated and ligated into the ClaI/EcoRI 
sites of pSLA3. pSLA3-H2/3-E3K was con- 
structed by cloning a HindIII/HindIII fragment, 
derived from GrAR2, into the Hind111 site of a 
Bluescript vector (pBLUE-H2/3). A pBLUE- 
H2/3 ClaI/KpnI fragment (1.3 kb) was placed in 
front of the E3K fragment in pSLA3-E3K (in 
ClaI and KpnI sites). pSLA3-8kb was constructed 
by integration of a 6.5 kb BamHI/KpnI frag- 
ment, derived from GrAR2, into the BamHI and 
KpnI sites in front of the E3K fragment in 
pSLA3-E3K. pSLA3-CRE-tk was constructed by 
ligation of a BamHI/PvuII fragment (containing 
two CRE consensus sequences derived from the 
human fibronectin gene; kindly provided by Dr. 
R. Offringa) into the BamHI/SmaI sites of 
pSLA3-tk (van Dijk et al., 1991). To obtain 
pSLA3-act, a pGEM7 polylinker region was in- 
serted in front of the tk promoter of the pSLA3-tk 
vector. A HindIII/XhoI fragment containing the 
Ott-6 minimal promoter was then cloned into the 
HindIII/XhoI sites of the polylinker region of 
the pSLA3-pl-tk vector (pSLA3-pl-act-tk). Fi- 
nally, the tk promoter was removed from pSLA3- 
pl-act-tk by using BgIII/ XhoI (pSLA3-act). 
p&43-act-E3K was constructed by insertion of 
the KpnI/EcoRI fragment, derived from pSLA3- 
E3k, into the SmaI site of the pSLA3-act. 
p&43-act-H3.1 and p&43-act-H3.2 were con- 
structed by cloning both Hind111 fragments (H3.1 
(= 411 bp, containing the AR promoter region) 
and H3.2 (= 610 bp, containing a large portion of 
the AR 5’ untranslated cDNA sequence)) sepa- 
rately into the Hind111 site of pSLA3-act. 
PSLA3-act-GRE was constructed by cloning a 
Hind111 fragment from pG-29G-tkCAT (Schule 
et al., 1988), into the Hind111 site of the pSLA3- 
act plasmid. 
Results 
AR mRNA expression 
When Sertoli cells were cultured in the pres- 
ence of FSH or dbcAMP for 5 h, a rapid but 
transient decrease in AR mRNA expression was 
observed (Fig. 2A). However, when FSH or db- 
CAMP was present for longer time periods (72 h), 
AR mRNA expression became elevated to values 
above the control level (FSH gave a 2.4 f 0.2-fold 
induction, and dbcAMP a 2.1 + 0.3-fold induc- 
tion; mean k SD of four experiments). Addition 
of the synthetic androgen R1881 to the cultures 
did not result in changes in AR mRNA expres- 
sion. Actin mRNA expression was not signifi- 
cantly affected by the hormone treatments (Fig. 
2B). 
Peritubular myoid cells showed a small de- 
crease in AR mRNA expression, 5 h and 72 h 
after addition of dbcAMP (30% decrease; Fig. 
3A). Such a decrease was also observed for the 
actin mRNA level (Fig. 3B), but not for GAPDH 
mRNA expression (Fig. 30. Therefore, it was 
concluded that dbcAMP had a small inhibitory 
effect on the expression of both actin and AR 
mRNAs in cultured peritubular myoid cells. This 
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Fig. 2. Effect of FSH, dbcAMP and R1881 on AR mRNA 
expression in cultured Sertoli cells. Sertoli cells from 15-day- 
old rats were cultured in the presence of ovine FSHS16 (500 
ng/ml), dbcAMP (0.5 mM) or R1881 (10-s M) for different 
time periods. 4hR1881, 8hR1881, 24hR1881= cultured for 4 
h, 8 h or 24 h in the presence of R1881; 5hdbcAMP, 
72hdbcAMP = cultured for 5 h, or 72 h in the presence of 
dbcAMP; ShFSH, 72hFSH = cultured for 5 h or 72 h in the 
presence of FSH. For Northern analysis, 20 pg of total RNA 
was applied per lane and analyzed using a human AR cDNA 
probe (A); a hamster actin cDNA probe (B) was used to 
verify whether equal amounts of mRNA were applied to each 
lane on the gel. 
effect, however, was different from the transient 
decrease (5 h) and gradual increase (72 h) of AR 
mRNA expression in dbcAMP-treated Sertoli 
cells. Incubation of peritubular myoid cell prepa- 
rations in the presence of FSH had no effect on 
AR mRNA expression, confirming that this cell 
preparation did not contain a substantial number 
of Sertoli cells. Addition of R1881 to the cultured 
peritubular myoid cells did not result in changes 
in the expression of AR mRNA or actin mRNA 
(Fig. 3A and 3B). 
In LNCaP cells, no short- or long-term regula- 
tion of AR mRNA expression by dbcAMP could 
be observed (Fig. 4A). Addition of R1881 to 
LNCaP cell cultures, however, did result in a 
marked reduction of the AR mRNA level (Fig. 
4A). This contrasts with the absence of an effect 
of R1881 on AR mRNA expression in Sertoli and 
peritubular myoid cell cultures (Figs. 2A and 
3A). Actin mRNA expression remained unal- 
tered during the different 
of LNCaP cells (Fig. 4B). 
Transfection of Sertoli cells 
Various methods were 
hormonal treatments 
examined to try to 
transfect primary Sertoli cell cultures. Monolay- 
ers of Sertoli cells from immature rats, cultured 
for several days in the presence or absence of 
hormones, showed very little uptake and expres- 
sion of various CAT reporter gene constructs. 
Higher construct uptake was observed using 
freshly isolated Sertoli cell clusters that were 
transfected shortly after isolation. Furthermore, 
the sensitivity of the assay was increased by using 
luciferase as a reporter gene; luciferase con- 
structs give a 30- to lOOO-fold higher signal than 
CAT constructs (de Wet et al., 1985, 1987; Ow et 
al., 1987). The transfected promoter constructs 
(Fig. 5; constructs l-5) produced a luciferase 
activity of approximately lo- to 30-fold over back- 
AR mRNA 
Act mRNA 
GAPDH mRNA 
Fig. 3. Effect of FSH, dbcAMP and R1881 on AR mRNA 
expression in cultured peritubular myoid cells. Peritubular 
myoid cells from 15-day-old rats were cultured in the presence 
of ovine FSH-S16 (500 ng/ml), dbcAMP (0.5 mM) or R1881 
(lo-” M) for different time periods, as described in the 
legend to Fig. 2. For Northern analysis, 20 Kg of total RNA 
was applied per lane and analyzed using a human AR cDNA 
probe (A); a hamster actin cDNA probe (B) and a rat 
GAPDH cDNA probe (C) were used to verify whether equal 
amounts of mRNA were applied to each lane on the gel. 
159 
..:’ s (” 
Act mRNA B 
i 
Fig. 4. Effect of FSH, dbcAMP and R1881 on AR mRNA 
expression in cultured LNCaP cells. LNCaP cells from pas- 
sages 45-50 were cultured in the presence of ovine FSHS16 
(500 ng/ml), dbcAMP (0.5 mM) or R1881 (10-s M) for 
different time periods, as described in the legend to Fig. 2. 
For Northern analysis, 20 pg of total RNA was applied per 
lane and analyzed using a human AR cDNA probe (A); a 
hamster actin cDNA probe (E) was used to verify whether 
equal amounts of mRNA were applied to each lane on the 
gel. 
ground. Hormone-induced changes in luciferase 
activity were interpreted as changes in AR pro- 
moter activity (de Wet et al., 1987). In some 
experiments P-galactosidase was used as an inter- 
nal control for transfection efficiency. Different 
plasmid preparations showed approximately 2- 
fold variation in transfection efficiency; however, 
no differences were observed in P-galactosidase 
transcription efficiency between the dbcAMP, 
R1881 or control incubated cells. 
Because the Sertoli cell clusters were isolated 
in the presence of trypsin and used within 4 h 
after isolation, there was the possibility that FSH 
receptors were damaged by the protease. There- 
fore, stimulation of transcription of the trans- 
fected promoter constructs was performed using 
dbcAMP rather than FSH. As a control, the 
mouse Sertoli cell line TM4 (Mather, 1980) was 
transfected and incubated with FSH. 
AR gene transcription 
Several constructs (Fig. 1) were used to study 
AR gene transcription in Sertoli and LNCaP 
CDR CDR CDR CDR CDR CDR CC 
UUUU -- II 
Constr.nr. 1 2 3 4 5 9 67 
Fig. 5. Luciferase activity in whole cell lysates from transfected Sertoli cells. The Sertoli cells were transfected with different 
constructs (construct numbers are presented below the figure), and cultured in the presence of dbcAMP (0.5 mM) or R1881 (lo-’ 
M). C = control; D = cultured for 24 h in the presence of dbcAMP; R = cultured for 24 h in the presence of R1881. The activity of 
constructs 6 and 7 was very low. The luciferase activity was measured in four different transfections in one representative 
experiment. The bars represent the mean k SD. 
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cells. In transfected Sertoli cells, transcription of 
the luciferase reporter gene from constructs con- 
taining AR promoter sequences was increased 
approximately 50-100% by incubation of the cells 
in the presence of dbcAMP (Fig. 5; constructs 
1-4). This increase was not found using construct 
5, that contained only 5’ untranslated cDNA 
sequences. A positive control, containing CAMP 
response elements (CREs), also showed a 1.5- to 
2-fold stimulated transcription. In primary Sertoli 
cell cultures, AR promoter activity was not stimu- 
lated by FSH (constructs 1-4; not shown), most 
likely due to loss of FSH receptors during the cell 
isolation procedure. However, when these con- 
structs were transfected into TM4 cells, their 
transcription was stimulated approximately 1.5- 
fold by FSH (not shown). 
The 1.5- to 2-fold stimulation of construct 
transcription by dbcAMP/FSH in the transfected 
Sertoli cells and TM4 cells indicates that FSH 
may stimulate the transcription of the AR gene in 
Sertoli cells, through the CAMP pathway. 
Addition of R1881 to the Sertoli cell cultures 
had no effect on the transcription of the trans- 
fected constructs (Fig. 5). 
In nuclear run-on experiments, performed on 
isolated Sertoli cell nuclei, no marked increase in 
AR gene transcription rate was observed when 
the nuclei were isolated after 24 or 72 h of 
culture of the cells in the presence of FSH (Fig. 
7A). 
Transfection of LnCaP cells 
In non-transfected LNCaP cells, cultured in 
the presence of R1881 for 8 or 24 h, a marked 
inhibition of AR mRNA expression was observed 
(Fig. 4A). However, LNCaP cells transfected with 
AR gene constructs (Fig. 1; constructs l-5) and 
cultured in the presence of R1881, did not show 
an inhibition of luciferase transcription (Fig. 6; 
only the pSLA3-H2/3 construct is shown, but all 
other constructs were also negative). A positive 
control construct containing a glucocorticoid :-e- 
sponse element showed a dose-dependent in- 
crease in transcription, up to 20-fold induction 
(Fig. 6). From these results it cannot be con- 
cluded that androgen-induced down-regulation of 
AR mRNA expression in LNCaP cells results 
from decreased AR gene transcription. Measure- 
ment of transfection efficiency in the different 
Con 1 O-l2 10-l' 1 O"O 1 O'O 1 o.8 10.' 
Rl881 concentra0on 
Fig. 6. Luciferase activity in whole cell lysates from transfected LNCaP cells. LNCaP cells were transfected with pSLA3-GRE-act 
(a positive control; shaded bars), and with pSLA3-H2/3-E3k (construct 2, an AR promoter containing construct; closed bars). 
After transfection, the cells were incubated for 24 h in the presence of different concentrations of R1881 (lOW’* to lo-’ M). The 
luciferase activity was measured in four different transfections in one representative experiment. The bars represent the 
mean k SD. 
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Fig. 7. Measurement of the initiation rate of AR gene tran- 
scrrption in cultured Sertoli cells (A) and LNCaP cells (B). 
Sertoli cells were cultured in the presence of ovine FSHS16 
(500 ng/ml), for 24 or 72 h. LNCaP cells were cultured in the 
presence of R1881 (lo-’ M), for 8 or 24 h. Nuclei were 
isolated and transcriptional run-on experiments were per- 
formed as described in Materials and methods. 24hFSH, 
72hFSH = cultured for 24 h or 72 h in the presence of FSH; 
ShR1881, 24hR1881= cultured for 8 h or 24 h in the presence 
of R1881; AR = androgen receptor; Act = actin; pTZ = 
control plasmid. The experiment was repeated 2 times with 
the same results. The autoradiograph shows the results from 
one experiment. 
treatment groups revealed no significant differ- 
ences. 
To study whether or not transcription of the 
native androgen receptor gene, possibly contain- 
ing one or several negative androgen response 
elements (nARE) far upstream or in one of the 
introns, can be regulated by androgens, a nuclear 
run-on experiment was performed. The results 
from the run-on assay indicated that AR gene 
transcription in LNCaP cells is subject to moder- 
ate down-regulation by androgens (Fig. 7B). Inhi- 
bition of AR gene transcription rate in LNCaP 
cells was quantitated using densitometric scan- 
ning. The measured values were 0.86/0.84 after 8 
h and 0.70/0.76 after 24 h of culture in the 
presence of R1881. 
Discussion 
Differential regulation of AR mRNA expression by 
FSH, dbcAMP and androgens 
With respect to androgen action, AR mRNA 
expression in LNCaP cells was reduced after the 
addition of androgens to the culture medium. 
Other authors have observed a similar down-reg- 
ulatory androgen effect in LNCaP cells (Quarmby 
et al., 1990; Tilley et al., 1990; Trapman et al., 
1990; Krongrad et al., 1991). Furthermore, andro- 
gen administration to castrated rats down-regu- 
lated AR mRNA expression in ventral prostate 
(Lubahn et al., 1988; Tan et al., 1988; Quarmby 
et al., 1990; Blok et al., 1992a), kidney, brain, 
coagulating gland (Quarmby et al., 1990) and 
epididymis (Quarmby et al., 1990; Blok et al., 
1992a). Such a down-regulatory androgen effect, 
however, was not found in cultured Sertoli and 
peritubular myoid cells (Blok et al., 1989; San- 
born et al., 1991). Furthermore, androgen with- 
drawal from the adult rat testis, by use of the 
toxic compound ethane dimethane sulphonate 
that eliminates Leydig cells, also did not result in 
altered testicular AR mRNA expression (Blok et 
al., 1991, 1992a). 
Regulation of AR mRNA expression by FSH The present data underline that regulation of 
is a cell-specific event, because Sertoli cells are AR mRNA expression in rat testis by FSH, db- 
the only cells in the male body that express de- CAMP and androgens is different, when com- 
tectable amounts of the FSH receptors (Dorring- pared with AR mRNA expression regulation in 
ton et al., 1975). We have shown (Blok et al., LNCaP cells or several other rat tissues and 
1992b) that addition of FSH to cultured imma- organs. 
ture Sertoli cells resulted in a short-term tran- 
sient decrease (5 h) in AR mRNA expression, 
that was followed by a long-term increase (24-72 
h). Dibutyryl-cyclic AMP (dbcAMP) mimicked the 
FSH effect, indicating that also for this effect 
CAMP is used as an important second messenger 
to transduce the FSH signal from the Sertoli cell 
surface to the interior of the cell. Obviously, the 
CAMP signal transduction pathway, activated by 
Q protein-coupled receptors, is not Sertoli cell 
specific. Therefore, we have tested whether the 
addition of dbcAMP to other AR containing cells 
might exert a similar effect on AR mRNA ex- 
pression. 
In peritubular myoid cells from the testis, a 
small decrease in AR mRNA expression was 
observed when the cells were cultured in the 
presence of dbcAMP (5 h and 72 h). In LNCaP 
cells there was no effect of dbcAMP at all. This 
contrasts with the marked regulatory effects of 
dbcAMP (or FSH through CAMP) on Sertoli cells. 
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AR gene transcription 
For the short-term (5 h) down-regulation of 
AR mRNA expression in Sertoli cells by FSH, it 
has been shown that the rate of initiation of AR 
gene transcription was not markedly changed 
(Blok et al., 1992b). The FSH/dbcAMP-induced 
decline in AR mRNA expression seems to be the 
result of a marked decrease in AR mRNA stabil- 
ity (Blok et al., 1992b). 
For the long-term (24-72 h) FSH-induced 
stimulation of AR mRNA expression in Sertoli 
cells, and for the androgen-induced decrease in 
AR mRNA expression in LNCaP cells, AR gene 
transcription was studied in the present experi- 
ments. 
Two different approaches were chosen to ex- 
amine AR gene transcription. First, several dif- 
ferent AR gene promoter regions were inserted 
in front of a reporter gene. These constructs were 
transfected into Sertoli and LNCaP cells, which 
were then incubated in the presence or absence 
of hormones. After 24 h, reporter activity was 
measured. Second, using a nuclear transcription 
elongation assay (run-on), the transcription initia- 
tion rate was measured in FSH-stimulated Sertoli 
cells (0, 24 and 72 h), and in androgen-treated 
LNCaP cells (0, 8, 24 h). 
Stimulation of AR gene transcription by FSH or 
dbcAMP in Sertoli cells 
Using different constructs that contained the 
AR gene promoter region, a stimulation of con- 
struct transcription by dbcAMP was observed in 
transfected Sertoli cells, that was not observed 
for the construct that contained only the 5’ un- 
translated region of the cDNA sequence. The 
transcription of a positive control, a CRE-con- 
taining construct, was stimulated 50%, which is 
low when compared to a 5- to 7-fold stimulation 
of the transcription of this CRE construct when 
transfected into other cell types (Dean et al., 
1989). In LNCaP cells we observed a 5-fold in- 
crease in transcription of the CRE construct (not 
shown). 
The results indicate that there is a small but 
reproducible increase, induced by dbcAMP, in 
the transcription of the AR promoter containing 
constructs transfected into Sertoli cells. Further- 
more, the present results suggest that sequences 
in the promoter region of the AR gene play a 
role in the stimulatory effect of FSH (dbcAMP) 
on the transcription of this gene in Sertoli cells. 
Analysis of the sequence of the AR promoter 
region (Baarends et al., 19901, however, revealed 
no known CRE consensus sequences that could 
be responsible for the observed effects. 
In the current investigations, the transcription 
of AR promoter containing constructs was ele- 
vated by only 50-100% upon dbcAMP addition 
to the Sertoli cell cultures. These differences 
were judged too small to warrant identification of 
the sequences that are involved in CAMP-induced 
regulation of AR gene transcription in Sertoli 
cells by means of mutation analysis. 
Inhibition of AR gene transcription by androgens in 
LNCaP cells 
The general concept of androgen action in- 
volves that androgens bind to the AR, that subse- 
quently becomes transformed to its DNA binding 
form and then regulates transcription of andro- 
gen responsive genes (Schrader et al., 1981; Beato, 
1990; Wahli and Martinez, 1991). LNCaP cells 
contain large amounts of AR protein, and these 
ARs become transformed to the tight nuclear 
binding form in the presence of R1881 (Veld- 
scholte et al., 1990). Furthermore, a clear down- 
regulatory effect of R1881 addition on AR mRNA 
expression (8-24 h) was found (Krongrad et al., 
1991). In the present experiments it was investi- 
gated whether these observations can be ex- 
plained by a reduced level of AR gene transcrip- 
tion. 
To this end, the AR gene promoter constructs 
were transfected into LNCaP cells, and assayed 
for their response to androgen treatment. The 
positive control, a construct containing a gluco- 
corticoid responsive element which can also be 
regulated by the androgen receptor (GRE; Schiile 
et al., 1988) cloned in front of the Ott-6 minimal 
promoter, showed a marked stimulation of tran- 
scription after androgen addition to the LNCaP 
cells. The transcription of the AR promoter con- 
structs, however, appeared not to be regulated by 
androgens. Although the constructs contained 
large portions of the 5’ upstream region of the 
AR gene promoter, these experiments do not 
exclude the possibility that androgen response 
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elements are located in other parts of the gene. 
For example for the C3 gene, encoding a compo- 
nent of prostatic binding protein, an androgen 
response element has been described in the first 
intron of the gene (Claessens et al., 1990; Tan et 
al., 1992). The putative nARE, however, can also 
be located further upstream, in an area of the 
AR gene that has not been investigated sofar. 
Nuclear run-on experiments were performed to 
investigate whether or not the native gene is 
subject to transcriptional regulation. 
Measurement of the transcription initiation 
rate of the AR gene in LNCaP cells indicated 
that androgen treatment resulted in a 30% reduc- 
tion of transcription. Therefore, androgen-in- 
duced inhibition of AR mRNA expression in 
LNCaP cells may result in part or completely 
from decreased AR gene transcription. 
In conclusion, regulation of the expression of 
the AR gene in Sertoli, peritubular myoid and 
LNCaP cells differs markedly. In Sertoli cells, 
FSH/dbcAMP can stimulate AR gene transcrip- 
tion, whereas androgens have no effect. In LNCaP 
cells, dbcAMP has no effect on AR mRNA ex- 
pression, while androgens inhibit AR gene tran- 
scription. In peritubular myoid cells neither db- 
CAMP nor androgens were found to have a 
marked effect on AR mRNA regulation. There- 
fore, it appears that the mode of control of AR 
gene transcription is cell type dependent. 
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